Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Avanir Pharmaceuticals)"
Count: 23
Selected: 0
NCT IDTitle
NCT03381664Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants
NCT02534038Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
NCT02496039Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)
NCT02477670Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia
NCT02442765Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT02402595Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts
NCT02336347A Phase 1 Study Comparing AVP-786 With AVP-923
NCT02174835A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers
NCT02153502Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
NCT01799941Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)
NCT01787747Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers
NCT01767129Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
NCT01667679Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura
NCT01584440Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease
NCT01366027PRISM Registry: Pseudobulbar Affect Registry Series
NCT01324232Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
NCT00573443Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS
NCT00113620Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy
NCT00056524Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
NCT00050232Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
NCT00021697Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS
NCT02176018Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine
NCT01832350Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease